《国际医学放射学杂志》投稿注意事项

国际医学放射学杂志ＩｎｔｅｒｎａｔｉｏｎａｌＪｏｕｒｎａｌｏｆＭｅｄｉｃａｌＲａｄｉｏｌｏｇｙ２０21Mar鸦44穴2雪
[2]Kim SH,Lee CH,Kim BH,et al.Typical and atypical imaging
findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging[J].J Comput Assist Tomogr,2012,36: 704-709.DOI:10.1097/RCT.0b013e3182706562.
[3]Huang B,Wu L,Lu XY,et al.Small intrahepatic cholangiocarcinoma
and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging[J].Radi－ology,2016,281:150–157.DOI:10.1148/radiol.2016151205. [4]Chen CZ,Rao SX,Ding Y,et al.Hepatocellular carcinoma20mm
or smaller in cirrhosis patients:early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine[J].Hepatol Int,2014,8:104-111.DOI:10.1007/ s12072-013-9467-7.
[5]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics[J].CA
Cancer J Clin,2015,65:87-108.DOI:10.3322/caac.21262.
[6]黄伟鹏,陈洁容,许建生,等.小肝癌的螺旋CT不典型表现并与
病理对照[J].实用放射学杂志,2006,22:1087-1090.Huang WP, Chen JR,Xu JS,et al.Spiral CT atypical appearances of small hepatocellular carcinoma with pathologic correlation[J].J Prac Radiol,2006,22:1087-1090.
[7]Kim R,Lee JM,Shin CI,et al.Differentiation of intrahepatic mass-
forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging[J].Eur Radiol,2016,26: 1808-1817.DOI:10.1007/s00330-015-4005-8.
[8]Bridgewater J,Galle PR,Khan SA,et al.Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma[J].J Hepatol,2014,60:1268-1289.DOI:10.1016/j.jhep.2014.01.021. [9]Min JH,Kim YK,Choi SY,et al.Intrahepatic mass-forming
cholangiocarcinoma:arterial enhancement patterns at MRI and prognosis[J].Radiology,2019,290:691-699.DOI:10.1148/radiol.
2018181485.
[10]Choi SH,Lee SS,Kim SY,et al.Intrahepatic cholangiocarcinoma in
patients with cirrhosis:differentiation from hepatocellular carcinoma
by using gadoxetic acid-enhanced MR imaging and dynamic CT[J].
Radiology,2017,282:771-781.DOI:10.1148/radiol.2016160639.
[11]Sirica AE,Gores GJ,Groopman JD,et al.Intrahepatic
cholangiocarcinoma:continuing challenges and translational advances[J].Hepatology,2019,69:1803-1815.DOI：10.1002/hep.
30289.Epub2019Mar25.
[12]Hartke J,Johnson M,Ghabril M.The diagnosis and treatment of
hepatocellular carcinoma[J].Semin Diagn Pathol,2017,34:153-159.
DOI:10.1186/s12957-016-0903-8.
[13]谢玉海,余永强,钱银锋,等.扩散加权成像在鉴别肝细胞肝癌和
周围型胆管细胞癌的价值[J].临床放射学杂志,2016,35:887-890.Xie YH，Yu YQ，Qian YF，et al．The value of DWI in differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J].J Clin Radiol,2016,35:887-890.DOI:
10.13437/ki.jcr.2016.06.017.
[14]袁灼彬,郑晓林,王惠媚,等.DWI定量分析在鉴别肝脏良恶性
病变的价值[J].影像诊断与介入放射学,2014,23:70-74．Yuan ZB,Zheng XL,Wang HM,et al．Quantitative analysis of diffusion-weighted MRI in the diagnosis of benign and malignant liver lesions [J].Diagn Imaging Interv Radiol,2014,23:70-74．DOI:10.3969/j.
issn.1005-8001.2014.01.016.
[15]Min JH,Kim YK,Choi SY,et al.Differentiation between
cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging:classification tree analysis applying capsule and septum[J].Eur J Radiol,2017,92:1-10.DOI:10.1016/ j.ejrad.2017.04.008.
[16]孙侠,靳二虎,王振常.MRI肝胆特异性对比剂Gd-EOB-DTPA
对小肝细胞癌的诊断研究进展[J].国际医学放射学杂志,2017, 40:298-303.Sun X,Jin EH,Wang ZC.The research progress of Gd-EOB-DTPA hepatobiliary-specific MRI contrast agent in the imaging diagnosis of small hepatocellular carcinoma[J].Int J Med Radiol,2017,40:298-303.DOI：10.19300/j.2017.Z4617.
（收稿2020-07-29）
本刊采用网上投稿（网址：www.ijmradiol.ac.cｎ）。

作者初次投稿需完善注册信息，务必完整、准确填写各项内容。

投稿时需上传稿件的word文件，文稿内应明确第一作者和通信作者的详细
联系方式。

稿件需遵照本刊稿约中的写作及格式要求，图表按顺序排列并插入文中。

文稿格式设
置为：字体“中文宋体，英文Times New Roman”，字号“5号”。

间距为段前、段后“0行”，行距“单行
倍距”。

上传稿件后，应提交加盖单位公章的介绍信、基金证明及签署好的论文协议（从本刊网站
首页下载专区下载模板，需稿件中全部署名作者按排序亲笔签名），经版权协议入口上传至系统。

稿件通过初审后作者将收到编辑部发送的收稿通知单。

请按通知要求及时缴纳稿件审理费，转账应在备注中注明稿件编号和第一作者姓名，以便稿件能及时处理。

本刊无外设及委托机构，未设置任何以个人名义开户的银行账号，也不会要求添加个人微
信核对信息。

敬请广大作者投稿时注意。

《国际医学放射学杂志》投稿注意事项
133。